カテゴリ： MarketLine, デンマーク, 企業調査

Novo Nordisk A/S：戦略・SWOT・企業財務分析

◆英語タイトル：Novo Nordisk A/S - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA8015162
◆発行会社（調査会社）：MarketLine
◆発行日：2017年9月30日
◆ページ数：52
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：デンマーク
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single UserUSD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Novo Nordisk A/S – Strategy, SWOT and Corporate Finance Report
Summary

Novo Nordisk A/S – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Novo Nordisk (or ‘the company’) is a global healthcare company engaged in providing diabetes and obesity care products. The company also has a leadership position in haemophilia, growth hormone therapy and hormone replacement therapy. Novo Nordisk operates in Europe, North America, China, Japan, Korea and other regions of the world. It is headquartered in Bagsvaerd, Denmark.

Scope

- Detailed information on Novo Nordisk A/S required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Novo Nordisk A/S in the form of a SWOT analysis
- An in-depth view of the business model of Novo Nordisk A/S including a breakdown and examination of key business segments
- Intelligence on Novo Nordisk A/S’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Novo Nordisk A/S, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Novo Nordisk A/S and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Novo Nordisk A/S as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Novo Nordisk A/S’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Novo Nordisk A/S: Company Overview
Novo Nordisk A/S: Overview and Key Facts
Novo Nordisk A/S: Overview
Novo Nordisk A/S: Key Facts
Novo Nordisk A/S: Key Employees
Novo Nordisk A/S: Key Employee Biographies
Novo Nordisk A/S: Major Products and Services
Novo Nordisk A/S: Company History
Novo Nordisk A/S: Management Statement
Novo Nordisk A/S: Locations and Subsidiaries
Novo Nordisk A/S: Key Competitors
Novo Nordisk A/S: Company Analysis
Novo Nordisk A/S: Business Description
Novo Nordisk A/S: SWOT Analysis
Novo Nordisk A/S: SWOT Overview
Novo Nordisk A/S: Strengths
Novo Nordisk A/S: Weaknesses
Novo Nordisk A/S: Opportunities
Novo Nordisk A/S: Threats
Novo Nordisk A/S: Corporate Financial Deals Activity
Novo Nordisk A/S: Financial Deals Overview
Novo Nordisk A/S: Targets and Partners
Novo Nordisk A/S: Top Deals 2013 – 2017YTD*
Novo Nordisk A/S: Advisors
Novo Nordisk A/S: Top Financial Advisors
Novo Nordisk A/S: Mergers and Acquisitions
Novo Nordisk A/S: Corporate Venturing
Novo Nordisk A/S: Partnership
Novo Nordisk A/S: Divestments
Novo Nordisk A/S: Recent Developments
Novo Nordisk A/S: News and Events Summary
Novo Nordisk A/S: Business Expansion
Novo Nordisk A/S: Contracts
Novo Nordisk A/S: Financial Performance
Novo Nordisk A/S: Market Developments
Novo Nordisk A/S: Red Flags/DistressSignals
Novo Nordisk A/S: Research & Development
Novo Nordisk A/S: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Novo Nordisk A/S: Key Facts
Table 2: Novo Nordisk A/S: Key Employees
Table 3: Novo Nordisk A/S: Locations and Subsidiaries
Table 4: Novo Nordisk A/S: Key Competitors
Table 5: Novo Nordisk A/S: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 6: Novo Nordisk A/S: Targets and Partners
Table 7: Novo Nordisk A/S: Top Deals 2013 - 2017YTD*
Table 8: Novo Nordisk A/S: Financial Advisor Ranking by Value (US$m)
Table 9: Novo Nordisk A/S: M&A Volume and Value Trend (2013 - YTD*2017)
Table 10: Novo Nordisk A/S: M&A Activity by Geography (2013 - YTD*2017)
Table 11: Novo Nordisk A/S: Corporate Venturing Volume and Value Trend (2013 - YTD*2017)
Table 12: Novo Nordisk A/S: Corporate Venturing by Geography (2013 - YTD*2017)
Table 13: Novo Nordisk A/S: Partnership Volume and Value Trend (2013 - YTD*2017)
Table 14: Novo Nordisk A/S: Partnership Trend by Deal Type (2013 - YTD*2017)
Table 15: Novo Nordisk A/S: Divestments Volume and Value Trend (2013 - YTD*2017)
Table 16: Novo Nordisk A/S: Divestments by Geography (2013 - YTD*2017)
Table 17: Novo Nordisk A/S: News and Events Summary
Table 18: Novo Nordisk A/S: Business Expansion
Table 19: Novo Nordisk A/S: Contracts
Table 20: Novo Nordisk A/S: Financial Performance
Table 21: Novo Nordisk A/S: Market Developments
Table 22: Novo Nordisk A/S: Red Flags/DistressSignals
Table 23: Novo Nordisk A/S: Research & Development
Table 24: Novo Nordisk A/S: Strategy and Operations

★海外企業調査レポート[Novo Nordisk A/S：戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • R1 RCM Inc (RCM)：企業の財務・戦略的SWOT分析
    R1 RCM Inc (RCM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Cellectis SA (ALCLS)：企業の財務・戦略的SWOT分析
    Summary Cellectis SA (Cellectis) is a clinical-stage biopharmaceutical company that research, develop and commercialise rational genome engineering technologies. The company pioneers gene editing company, deploying core proprietary technologies to develop off-the-shelf immunotherapies to target and …
  • Psychemedics Corp (PMD)：企業の財務・戦略的SWOT分析
    Summary Psychemedics Corp (Psychemedics) is a clinical laboratory service provider. The company provides testing for drugs abuse using hair analysis. It offers drug panel, workplace drug testing, personal drug testing kits, school drug testing, alcohol testing, synthetic cannabinoids testing, benzod …
  • Fibrocell Science Inc (FCSC)：企業の財務・戦略的SWOT分析
    Fibrocell Science Inc (FCSC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Omron Healthcare Co Ltd：医療機器：M&Aディール及び事業提携情報
    Summary Omron Healthcare Co Ltd (Omron Healthcare), a subsidiary of Omron Corp, is a provider of medical equipment for health monitoring and therapy. The company offers blood pressure monitors, digital thermometers, body fat meters, pedometers, nebulizers, body composition monitors and electric toot …
  • Orkla ASA：企業の戦略・SWOT・財務情報
    Orkla ASA - Strategy, SWOT and Corporate Finance Report Summary Orkla ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Black Knight Inc (BKI)：企業の財務・戦略的SWOT分析
    Black Knight Inc (BKI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • CIBC Wealth Management：企業の戦略・SWOT・財務分析
    CIBC Wealth Management - Strategy, SWOT and Corporate Finance Report Summary CIBC Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Einstein Noah Restaurant Group, Inc. (Foodservice)：戦略・SWOT・企業財務分析
    Einstein Noah Restaurant Group, Inc. (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary Einstein Noah Restaurant Group, Inc. (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's struct …
  • Therapix Biosciences Ltd (TRPX)：企業の財務・戦略的SWOT分析
    Therapix Biosciences Ltd (TRPX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • The Menarini Group：企業のM&A・事業提携・投資動向
    The Menarini Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Menarini Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Minor International PCL：企業の戦略・SWOT・財務情報
    Minor International PCL - Strategy, SWOT and Corporate Finance Report Summary Minor International PCL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Methanol Chemicals Co (2001)：企業の財務・戦略的SWOT分析
    Methanol Chemicals Co (2001) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • China Pharma Holdings Inc (CPHI)：企業の財務・戦略的SWOT分析
    China Pharma Holdings Inc (CPHI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • AviChina Industry & Technology Co., Ltd. (2357)：企業の財務・戦略的SWOT分析
    AviChina Industry & Technology Co., Ltd. (2357) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • University of Pennsylvania-製薬・医療分野：企業M&A・提携分析
    Summary University of Pennsylvania (UOP) is an educational university that provides distance learning facilities for professional courses. The university offers courses such as art and archaeology, accounting, biochemistry, bioengineering, biomedical graduate studies, city and regional planning, cri …
  • Eagle Pharmaceuticals Inc (EGRX)：企業の財務・戦略的SWOT分析
    Eagle Pharmaceuticals Inc (EGRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • J.K. Cement Ltd. (JKCEMENT)：企業の財務・戦略的SWOT分析
    J.K. Cement Ltd. (JKCEMENT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • American Vanguard Corp (AVD)：企業の財務・戦略的SWOT分析
    American Vanguard Corp (AVD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • ethris GmbH：製薬・医療：M&Aディール及び事業提携情報
    Summary Ethris GmbH (Ethris) is a biotech company that develops RNA-based therapies. The company develops therapeutics based on its proprietary platform technologies. It uses technologies including magnetovax and SNIM RNA. Ethris’ magnetovax is a platform for personalized tumor vaccines localized an …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆